Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The ILEUS Study: A Phase 2 Randomized Controlled Trial Investigating Alvimopan for Enhanced Gastrointestinal Recovery After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Next Previous
Trial Profile

The ILEUS Study: A Phase 2 Randomized Controlled Trial Investigating Alvimopan for Enhanced Gastrointestinal Recovery After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 May 2018

At a glance

  • Drugs Alvimopan (Primary)
  • Indications Postoperative ileus
  • Focus Therapeutic Use
  • Acronyms ILEUS

    • Most Recent Events

    • 02 May 2018 Planned End Date changed from 1 Dec 2019 to 1 Mar 2021.
    • 02 May 2018 Planned primary completion date changed from 1 Dec 2019 to 1 Mar 2020.
    • 02 May 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top